VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes

Filter search : Quote Research All


Companies for search string : EPS

EPSOM Properties Ltd. Hulta Pharma [BSE: 531155 || NSE: NA ]

Reports for search string : EPS

Minda Corporation: Automation is likely to drive both revenue growth and margins
Going forward SPA Securities believe shifting to electronification and automation is likely to drive both revenue growth and margins of Minda Corp. At CMP of INR 184, the stock is trading at 40x FY17 ...
SPA Securities, 17 Nov 2017
Indraprastha Gas Q2FY18: Revenue increased by 16.31%; Buy at CMP
The Company’s revenue for the Q2 FY18 rose by 16.31% to Rs.12454.70 mn from Rs.10708.50 mn, when compared with the prior year period. EBIDTA is Rs.3065.60 mn in Q2 FY18 as compared to Rs.2600.30 mn Q2...
Firstcall India Equity, 17 Nov 2017
Kovai Medical Center and Hospital Q2FY18: Net profit grew 3.49%; Overweight
The company has achieved a turnover of Rs. 1547.70 million for the 2nd quarter of the FY 2017-18 as against Rs. 1365.57 million in the corresponding quarter of the previous year, an increase of 13.34%...
Firstcall India Equity, 17 Nov 2017
Kalpataru Power Transmission Q2FY18: Expecting a strong year ahead; Accumulate
The stock is trading at 14x core FY19EPS. We believe the strong outlook in domestic T&D market and increasing presence in high growth areas like Railways should help the company deliver 21% earnings C...
Prabhudas Lilladher, 16 Nov 2017
Manpasand Beverages Q2FY18: Growth plans on track; BUY
We expect Fruits up to drive growth as new units will have 40% capacity for fruits Up. We estimate 38% PAT CAGR over FY17-20 and value the stock at 30xMarch20 EPS. Buy with 18-month target price of Rs...
Prabhudas Lilladher, 16 Nov 2017
Shankara Building Products: Net profit jumps 23.19% in Q2FY18; Overweight
At the current market price of Rs. 1475.25, the stock P/E ratio is at 45.88X F Y18E and 40.07 F Y19E respectively. Government's focus on various measures to improve the confidence of Individual Home B...
Firstcall India Equity, 16 Nov 2017
Sterling Tools Q2FY18: Firstcall overweight for medium to long term investment
At the current market price of Rs. 300.90, the stock P/E ratio is at 23.15 x F Y18E and 20.43 X F Y19E respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 9% and 26% over ...
Firstcall India Equity, 16 Nov 2017
Carborundum Universal posts strong growth in Q2FY18; Buy for an upside of 30%
The company is currently trading at 38.06x of TTM eps of Rs 9.72. Looking at increase in production capabilities, decent financials & strong industry outlook, we recommend “Buy” on the stock with for...
Hem Securities, 16 Nov 2017
Dhanuka Agritech Q2FY18: Firstcall overweight for medium to long term investment
For the quarter ended Q2 FY18, EBITDA stood at Rs.774.43 mn as against Rs.750.56 mn in the corresponding period of the previous year. During Q2 FY18, Profit before tax stood at Rs.736.10 mn against Rs...
Firstcall India Equity, 16 Nov 2017
Rushil Decor Q2FY18: Firstcall overweight for medium to long term investment
The company has reported an EPS of Rs. 5.92 for the 2nd quarter as against an EPS of Rs. 4.89 in the corresponding quarter of the previous year. Net Sales and Operating Profit of the company are expec...
Firstcall India Equity, 15 Nov 2017
Pidilite Industries Q2FY18: Early signs of recovery, margins a risk, Accumulate
Long term outlook seems intact as PIDI continues to invest in distribution expansion in small towns and product innovations in adhesives, sealants and more importantly construction chemicals.
Prabhudas Lilladher, 15 Nov 2017
Aarti Industries: Accumulate with a revised target price
Burgeoning middle class population and low per capita consumption of chemicals (one-tenth of world average) would invigorate Indian speciality chemical industry - industry is set to touch $70 bn by FY...
CD Equisearch Pvt Ltd, 15 Nov 2017
Alembic Pharma: Business remains under pressure - assign SHORT
Alembic Pharma’s (ALPM) 2QFY18 sales (-10% yoy to Rs 7.9bn) fell short of estimates due to below-expected US and domestic sales. However, EBITDA/PAT at Rs 1.8bn/1.2bn came in ahead of EE mainly on acc...
Equirus Securities, 14 Nov 2017
Balkrishna Industries Q2 Results: Margins and volume growth to remain strong; retain ADD
BIL’s 2QFY18 volumes grew by a strong 16% yoy and 6% qoq, surprising positively in a seasonally weak quarter. Industry leader Michelin’s specialty tyre sales grew 13% yoy in Sep’17 quarter, pointing t...
Equirus Securities, 14 Nov 2017
L&T Technology Services 2QFY18 Results: Margin recovery could do wonders; retain ADD
L&T Technology Services (LTTS) 2QFY18 earnings were good on revenue but „not so‟ on margins. 2Q US$ revenue growth of 9.2% was led by organic growth (~7.2%, large deal conversion & traction in t...
Equirus Securities, 14 Nov 2017
Torrent Pharma Q2FY18: Expanding domestic footprint with Unichem acquisition - Upgrade to ADD
Torrent Pharmaceutical Limited‟s (TRP) 2QFY18 results were slightly below EE owing to a topline miss due to one-offs in Brazil. However, a strong rebound in the domestic market came as a positiv...
Equirus Securities, 14 Nov 2017
Century Plyboards Q2FY18: Plywood demand to see gradual recovery; maintain Long
CPBI posted plywood volume/revenue declines of 2%/12% due to slower-than-expected restocking at the dealer level. Laminate volumes grew 10% yoy and revenues 18% yoy.
Equirus Securities, 14 Nov 2017
Torrent Pharma Q2FY18: Muted Quarterly Show; Unichem Deal to Boost Domestic Volume
Envisaging a healthy growth in India and Brazil businesses led by new launches and improvement in sale force productivity, we maintain our BUY recommendation and Target Price of Rs 1,450, valuing the ...
Reliance Securities, 14 Nov 2017
Nestle Q2FY18: Strong Operational Performance; Valuations Cap Upside
Rolling over our estimates to CY19E, we expect Nestle to post net revenues of Rs114.6bn/ Rs130.6bn and net profit of Rs15.4bn/Rs18bn in CY18E and CY19E, respectively.
Reliance Securities, 14 Nov 2017
Cera Sanitaryware: Demand recovery from Q4FY18 to drive growth; maintain ADD
Cera Sanitaryware’s (CRS) 2QFY18 sales were 10% above EE (+18% yoy) while EBITDA was in line (+8% yoy) with EBITDA margins coming in at 15.6%, 145bps lower yoy on higher outsourcing and other expenses...
Equirus Securities, 14 Nov 2017
View All

Intraday Tips

What are technical calls?

View Stock Advice by: